Befotertinib
Modify Date: 2024-01-04 18:24:28
Befotertinib structure
|
Common Name | Befotertinib | ||
|---|---|---|---|---|
| CAS Number | 1835667-63-4 | Molecular Weight | 567.61 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H32F3N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BefotertinibBefotertinib (D-0316) is the third-generation EGFR tyrosine kinase inhibitor. Befotertinib can be used for the research of EGFR T790M-positive non-small cell lung cancer (NSCLC)[1]. |
| Name | Befotertinib |
|---|
| Description | Befotertinib (D-0316) is the third-generation EGFR tyrosine kinase inhibitor. Befotertinib can be used for the research of EGFR T790M-positive non-small cell lung cancer (NSCLC)[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR tyrosine kinase[1] |
| References |
| Molecular Formula | C29H32F3N7O2 |
|---|---|
| Molecular Weight | 567.61 |